![]()
|
|
||||||||
(Received for publication, May 14, 1996, and in revised form, August 28, 1996)
From the Ludwig Institute for Cancer Research, Melbourne Tumour
Biology Branch, P.O. Royal Melbourne Hospital, Victoria 3050, Australia
The leukemia inhibitory factor/interleukin 6 (LIF/IL6) family of cytokines promotes cell type-specific pleiotropic
effects by engaging multimeric receptor complexes that share the common affinity converter/signal transducing subunit gp130. While the maintenance of embryonic stem (ES) cell self-renewal is an activity unique to this family of cytokines, the intracellular signaling events
mediated by gp130 remain largely unknown. Here we show a rapid and
transient increase in the specific activity of the Src-related kinase
Hck as well as of the Janus kinases Jak1, Jak2, and Tyk2 following
treatment of ES cells with LIF or a combination of IL6 plus a soluble
form of the IL6 receptor. Within 2 min of stimulation, we also observed
increased tyrosine phosphorylation of SHC, activation of the guanidine
nucleotide exchange activity on p21ras, and an electrophoretic
mobility shift of MAP kinase. Functional involvement of Hck and
p21ras activation in gp130-mediated signaling is supported by
the finding that the introduction of constitutively activated Hck or
v-Ha-ras partially alleviates the requirement of ES cells
for LIF to remain undifferentiated. In contrast, suppression of Jak1 in
ES cells by antisense technology increased the amount of LIF required
to retain their pluripotentiality. These results are consistent with the notion that gp130-mediated suppression of ES cell differentiation depends on signaling through at least two cascades, namely a
p21ras-dependent pathway that possibly involves
Hck, as well as a Jak kinase-dependent pathway.
This article has been cited by other articles:
![]() |
M. P. Storm, H. K. Bone, C. G. Beck, P.-Y. Bourillot, V. Schreiber, T. Damiano, A. Nelson, P. Savatier, and M. J. Welham Regulation of Nanog Expression by Phosphoinositide 3-Kinase-dependent Signaling in Murine Embryonic Stem Cells J. Biol. Chem., March 2, 2007; 282(9): 6265 - 6273. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Kim, A. L. Clark, A. Kiss, J. W. Hahn, R. Wesselschmidt, C. J. Coscia, and M. M. Belcheva {micro}- and {kappa}-Opioids Induce the Differentiation of Embryonic Stem Cells to Neural Progenitors J. Biol. Chem., November 3, 2006; 281(44): 33749 - 33760. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Nur-E-Kamal, I. Ahmed, J. Kamal, M. Schindler, and S. Meiners Three-Dimensional Nanofibrillar Surfaces Promote Self-Renewal in Mouse Embryonic Stem Cells Stem Cells, February 1, 2006; 24(2): 426 - 433. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Meyn III, S. J. Schreiner, T. P. Dumitrescu, G. J. Nau, and T. E. Smithgall Src Family Kinase Activity Is Required for Murine Embryonic Stem Cell Growth and Differentiation Mol. Pharmacol., November 1, 2005; 68(5): 1320 - 1330. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. S. Lazo Live Long and Prosper Mol. Pharmacol., November 1, 2005; 68(5): 1193 - 1195. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Foshay, G. Rodriguez, B. Hoel, J. Narayan, and G. I. Gallicano JAK2/STAT3 Directs Cardiomyogenesis Within Murine Embryonic Stem Cells In Vitro Stem Cells, April 1, 2005; 23(4): 530 - 543. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. J. Woolf, W. Prudhomme, L. Daheron, G. Q. Daley, and D. A. Lauffenburger Bayesian analysis of signaling networks governing embryonic stem cell fate decisions Bioinformatics, March 15, 2005; 21(6): 741 - 753. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. R. D. Paling, H. Wheadon, H. K. Bone, and M. J. Welham Regulation of Embryonic Stem Cell Self-renewal by Phosphoinositide 3-Kinase-dependent Signaling J. Biol. Chem., November 12, 2004; 279(46): 48063 - 48070. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Hamazaki, M. Oka, S. Yamanaka, and N. Terada Aggregation of embryonic stem cells induces Nanog repression and primitive endoderm differentiation J. Cell Sci., November 1, 2004; 117(23): 5681 - 5686. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Anneren, C. A. Cowan, and D. A. Melton The Src Family of Tyrosine Kinases Is Important for Embryonic Stem Cell Self-renewal J. Biol. Chem., July 23, 2004; 279(30): 31590 - 31598. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. K. Humphrey, G. M. Beattie, A. D. Lopez, N. Bucay, C. C. King, M. T. Firpo, S. Rose-John, and A. Hayek Maintenance of Pluripotency in Human Embryonic Stem Cells Is STAT3 Independent Stem Cells, July 1, 2004; 22(4): 522 - 530. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Prudhomme, G. Q. Daley, P. Zandstra, and D. A. Lauffenburger Multivariate proteomic analysis of murine embryonic stem cell self-renewal versus differentiation signaling PNAS, March 2, 2004; 101(9): 2900 - 2905. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. Abbud, R. Kelleher, and S. Melmed Cell-Specific Pituitary Gene Expression Profiles after Treatment with Leukemia Inhibitory Factor Reveal Novel Modulators for Proopiomelanocortin Expression Endocrinology, February 1, 2004; 145(2): 867 - 880. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Ernst, M. Inglese, G. M. Scholz, K. W. Harder, F. J. Clay, S. Bozinovski, P. Waring, R. Darwiche, T. Kay, P. Sly, et al. Constitutive Activation of the Src Family Kinase Hck Results in Spontaneous Pulmonary Inflammation and an Enhanced Innate Immune Response J. Exp. Med., September 2, 2002; 196(5): 589 - 604. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Viswanathan, T. Benatar, S. Rose-John, D. A. Lauffenburger, and P. W. Zandstra Ligand/Receptor Signaling Threshold (LIST) Model Accounts for gp130-Mediated Embryonic Stem Cell Self-Renewal Responses to LIF and HIL-6 Stem Cells, March 1, 2002; 20(2): 119 - 138. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Boeuf, K. Merienne, S. Jacquot, D. Duval, M. Zeniou, C. Hauss, B. Reinhardt, Y. Huss-Garcia, A. Dierich, D. A. Frank, et al. The Ribosomal S6 Kinases, cAMP-responsive Element-binding, and STAT3 Proteins Are Regulated by Different Leukemia Inhibitory Factor Signaling Pathways in Mouse Embryonic Stem Cells J. Biol. Chem., November 30, 2001; 276(49): 46204 - 46211. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Badache and N. E. Hynes Interleukin 6 Inhibits Proliferation and, in Cooperation with an Epidermal Growth Factor Receptor Autocrine Loop, Increases Migration of T47D Breast Cancer Cells Cancer Res., January 1, 2001; 61(1): 383 - 391. [Abstract] [Full Text] |
||||
![]() |
C. J. Auernhammer and S. Melmed Leukemia-Inhibitory Factor--Neuroimmune Modulator of Endocrine Function Endocr. Rev., June 1, 2000; 21(3): 313 - 345. [Abstract] [Full Text] |
||||
![]() |
Y. Y. Wu and R. A. Bradshaw Activation of the Stat3 Signaling Pathway Is Required for Differentiation by Interleukin-6 in PC12-E2 Cells J. Biol. Chem., January 21, 2000; 275(3): 2147 - 2156. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Lane, A. C. Chen, S. D. Roman, F. Derguini, and L. J. Gudas Removal of LIF (leukemia inhibitory factor) results in increased vitamin A (retinol) metabolism to 4-oxoretinol in embryonic stem cells PNAS, November 9, 1999; 96(23): 13524 - 13529. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Ernst, U. Novak, S. E. Nicholson, J. E. Layton, and A. R. Dunn The Carboxyl-terminal Domains of gp130-related Cytokine Receptors Are Necessary for Suppressing Embryonic Stem Cell Differentiation. INVOLVEMENT OF STAT3 J. Biol. Chem., April 2, 1999; 274(14): 9729 - 9737. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Raz, C.-K. Lee, L. A. Cannizzaro, P. d'Eustachio, and D. E. Levy Essential role of STAT3 for embryonic stem cell pluripotency PNAS, March 16, 1999; 96(6): 2846 - 2851. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Tomida, T. Heike, and T. Yokota Cytoplasmic Domains of the Leukemia Inhibitory Factor Receptor Required for STAT3 Activation, Differentiation, and Growth Arrest of Myeloid Leukemic Cells Blood, March 15, 1999; 93(6): 1934 - 1941. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Niwa, T. Burdon, I. Chambers, and A. Smith Self-renewal of pluripotent embryonic stem cells is mediated via activation of STAT3 Genes & Dev., July 1, 1998; 12(13): 2048 - 2060. [Abstract] [Full Text] |
||||
![]() |
M. Hallek, P. Leif Bergsagel, and K. C. Anderson Multiple Myeloma: Increasing Evidence for a Multistep Transformation Process Blood, January 1, 1998; 91(1): 3 - 21. [Full Text] [PDF] |
||||
![]() |
H. Boeuf, C. Hauss, F. D. Graeve, N. Baran, and C. Kedinger Leukemia Inhibitory Factor-dependent Transcriptional Activation in Embryonic Stem Cells J. Cell Biol., September 22, 1997; 138(6): 1207 - 1217. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Starr, U. Novak, T. A. Willson, M. Inglese, V. Murphy, W. S. Alexander, D. Metcalf, N. A. Nicola, D. J. Hilton, and M. Ernst Distinct Roles for Leukemia Inhibitory Factor Receptor alpha -Chain and gp130 in Cell Type-specific Signal Transduction J. Biol. Chem., August 8, 1997; 272(32): 19982 - 19986. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Uozumi, Y. Hiroi, Y. Zou, E. Takimoto, H. Toko, P. Niu, M. Shimoyama, Y. Yazaki, R. Nagai, and I. Komuro gp130 Plays a Critical Role in Pressure Overload-induced Cardiac Hypertrophy J. Biol. Chem., June 15, 2001; 276(25): 23115 - 23119. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |